UBS raised the firm’s price target on RXO Inc. to $31 from $22 and keeps a Neutral rating on the shares. RXO reported Q2 results modestly above consensus estimates, but the company pointed to soft truckload brokerage volumes in July down high single digits year over year, the analyst tells investors in a research note. The company is anticipating improving volumes in August and September, UBS notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO, Inc. Presents Supplementary Fiscal Performance Insights
- RXO Inc. price target raised to $30 from $24 at Barclays
- RXO partners with Shiplify to improve invoice transparency for LTL customers
- RXO Inc. price target raised to $25 from $16 at JPMorgan
- RXO Inc. price target raised to $25 from $22 at Stephens